TABLE 5.

T. gondii GRA6 serotypes and association with clinical aspects in Europe

Pathology (no. of samples)% (no.) of samples with indicated GRA6 serotype(s)
III/IIIMixedbNDc
Congenital (44)65.9 (29)11.4 (5)0 (0)22.7 (10)
Othera (6)66.7 (4)0 (0)0 (0)33.3 (2)
Immunocompromised asymptomatic (31)58.1 (18)6.5 (2)9.7 (3)25.8 (8)
Immunocompetent asymptomatic (130)43.1 (56)10 (13)7.7 (10)39.2 (51)
  • a Two cases of cerebral and one of pulmonary toxoplasmosis in HIV patients and three cases of ocular toxoplasmosis.

  • b Mixed, serum sample reacted with both peptides.

  • c ND, not determined because serum samples had OD indices that were below the cutoff values. Cutoff values were 0.088 for GRA6 II and 0.076 for GRA6 I/III.